BTAI BioXcel Therapeutics, Inc.

NEUTRAL Impact: 3/10 8-K

Horizon days Filed Mar 11, 2026 Processed 3mo ago SEC 0001104659-26-026409

8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)

Final — all horizons settled through T+60d

BTAI ▼ -28.71% at T+60d

NEUTRAL call ✗ call lost -28.71% · α vs SPY -39.41% · entry $1.55 → $1.11

Last close $1.14 (close Jun 12) · -26.45% from $1.55 entry

Entry anchored
Mar 11, 03:58 PM ET
via Databento tick

T+1d

-3.87%

call -3.87% · α -3.27%

$1.49

settled 3mo ago

T+5d

+3.23%

call +3.23% · α +4.20%

$1.60

settled 3mo ago

T+20d

-31.61%

call -31.61% · α -33.59%

$1.06

settled 2mo ago

T+60d

-28.71%

call -28.71% · α -39.41%

$1.11

settled 10d ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. The filing is an 8-K with Items 1.01 (Entry into Material Agreement) and 9.01 (Financial Statements and Exhibits), suggesting a potential new agreement or contract was announced, but no details are accessible to assess its nature or impact.

Actionable Insight

Wait for the actual filing to be available to assess the material agreement's impact. Monitor for press releases or investor communications from BioXcel Therapeutics that may disclose further details.

Key Facts

Filing type is 8-K, indicating a material event.
Items reported: 1.01 (Entry into Material Agreement) and 9.01 (Financial Statements and Exhibits).
No document content available to determine the agreement's nature, parties involved, or financial terms.
Market cap of BTAI is $34M as per snapshot.

Financial Impact

Unknown — no financial details available from the filing.

Risk Factors

Inability to assess potential dilution, cash impact, or strategic implications due to missing data.
Risk of delayed reaction if the agreement is significant and already priced in by the market.

Market Snapshot

Exchange

Nasdaq

Documents Analyzed

Report based on filing metadata.

8 reports for BTAI

T+1T+5T+20T+60

100% Hit rate 4 of 4 directional calls best @ T+20▲ +29.03%Mar 10, 2026

Filters

Reports for BTAI — sortable, filterable
	Type				Now
May 22, 2026 23d ago	Insider Cluster BEARISH ★ 5/10	$1.22 $1.19	▲ +2.46%	▲ +3.67%	$1.14 (+6.56%)
May 20, 2026 25d ago	144 NEUTRAL ★ 2/10	$1.14 $1.17	▲ +2.63%	▲ +0.78%	$1.14 (−0.00%)
May 15, 2026 4w ago	8-K NEUTRAL ★ 6/10	$1.14 $1.13	▼ −0.88%	▼ −1.84%	$1.14 (−0.00%)
May 15, 2026 4w ago	Press Release BEARISH ★ 6/10	$1.14 $1.13	▲ +0.88%	▲ +1.84%	$1.14 (+0.00%)
Apr 17, 2026 8w ago	8-K BEARISH ★ 6/10	$1.20 $1.09	▲ +9.17%	▲ +10.08%	$1.14 (+5.00%)
Mar 27, 2026 11w ago	Press Release MIXED ★ 6/10	$1.26 $1.14	▼ −9.52%	▼ −13.39%	$1.14 (−9.52%)
Mar 11, 2026 13w ago	8-K NEUTRAL ★ 3/10	$1.55 $1.60	▲ +3.23%	▲ +4.20%	$1.14 (−26.45%)
Mar 10, 2026 13w ago	Press Release BEARISH ★ 7/10	$1.55 $1.73	▼ −11.61%	▼ −12.52%	$1.14 (+26.45%)

US Market Status

Market Closed — Opens in 4h 15m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access